Example：10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
Correction for Oh et al., “Development of a Broth Microdilution Method for Exebacase Susceptibility Testing” Antimicrobial Agents and Chemotherapy (IF5.191), Pub Date : 2021-09-17, DOI: 10.1128/aac.01658-21 Jun T. Oh, Jane E. Ambler, Cara Cassino, Raymond Schuch
Volume 65, no. 7, e02587-20, 2021, https://doi.org/10.1128/AAC.02587-20. In Table 4, a single methicillin-susceptible Staphylococcus aureus isolate inhibited by 0.12 μg/ml of exebacase is presented, and the remaining 148
isolates tested have an exebacase MIC range of 0.25 to 1 μg/ml. Further investigation
of the isolate with an exebacase MIC of 0.12 μg/ml to confirm bacterial identification
(by MALDI-TOF) and MIC revealed the isolate to be Staphylococcus pseudintermedius. Based on this finding, the authors wish to correct Table 4 and the corresponding
text that refers to the S. aureus MIC data accordingly. With these corrections, the interpretation and conclusions
of the article remain the same.